| NAME |
SEMAGLUTIDE(WT LOSS) 1MG/0.5ML INJ,SOLN,PEN,0.5ML |
| VA GENERIC NAME |
SEMAGLUTIDE |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Semaglutide_(Wegovy)_(2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| FORMULARY DESIGNATOR TEXT |
|
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
1 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/0.5ML |
| NATIONAL FORMULARY NAME |
SEMAGLUTIDE INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2021-06-17 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
SEMAGLUTIDE WL 1MG/0.5ML PEN 0.5ML |
| VA PRODUCT IDENTIFIER |
S0925 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
EA |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4040578 |
| EFFECTIVE DATE/TIME |
-
- 2021-06-17 00:00:00
- STATUS: ACTIVE
-
- 2021-06-17 00:00:00
- STATUS: ACTIVE
-
- 2021-06-17 00:00:00
- STATUS: ACTIVE
|